OREX-1019

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameOREX-1019
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNociceptin receptor agonistsKappa opioid receptor antagonistsMu opioid receptor agonists +[4] 
TargetsNociceptin receptorMu opioid receptorKappa opioid receptor +[4] 
Therapy Area/IndicationsCocaine-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bath (The)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrexigen Therapeutics IncUniversity Of Bath (The)
Active IndicationsN/A
Inactive IndicationsCocaine-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A